atezolizumab,cobimetinib,talazoparib,abemaciclib,pembrolizumab,regorafenib,sunitinib,temsirolimus,palbociclib,ipilimumab,larotrectinib,vemurafenib,olaparib,futibatinib,crizotinib,nivolumab,trastuzumab,entrectinib,tucatinib,pertuzumab
seagen,merck,eli lilly,bayer,bms,roche,astrazeneca,pfizer,otsuka
['tapur', 'temsirolimus', 'sirolimus']
#cedarssinaicancer at #aacr23. dr. kristopher wentzel is lead author on the poster temsirolimus in patients with solid #tumors with pten mutation: results from the targeted agent and profiling utilization registry (tapur) study presented at 6:00am pt. 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.